GCANRx Announces Approval of Phase II Clinical Trial to Treat Autism Related Spectrum Disorders BALTIMORE, July 05, 2023 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a publicly traded biopharmaceutical company pioneering development of next...